CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-18 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −5,000 | 5,314 | ||
| 2018-12-12 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +5,000 | $0.94 | $5K | 22,309 |
| 2018-12-12 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −5,000 | 4,497 | ||
| 2018-11-27 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +3,000 | $0.94 | $3K | 117,847 |
| 2018-11-27 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −3,000 | 1,420 | ||
| 2018-11-13 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +4,000 | $0.94 | $4K | 16,100 |
| 2018-11-13 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −4,000 | 9,497 | ||
| 2018-11-13 | Koenig Scott President and CEO | Exercise or conversion | +40,000 | $0.94 | $38K | 173,163 |
| 2018-11-13 | Koenig Scott President and CEO | Exercise or conversion · Employee stock option (right to buy) | −40,000 | 39,897 | ||
| 2018-10-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion | +3,000 | $0.94 | $3K | 12,100 |
| 2018-10-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Exercise or conversion · Employee stock option (right to buy) | −3,000 | 13,497 | ||
| 2018-05-17 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Galbraith Kenneth Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Ferrante Karen Jean Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | SIEGEL JAY PHILIP Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Costa Paulo F Director | Grant or award · Stock Option (right to buy) | +6,293 | 6,293 | ||
| 2018-05-17 | HURWITZ EDWARD Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | STUMP DAVID C Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2018-05-17 | Jackson Scott Thomas Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 |
Page 31 of 35 · 684 trades